Eli Lilly and Company to Expand Insulin-Manufacturing Facilities

Eli Lilly & Co. (LLY) plans to expand its Indianapolis insulin-manufacturing facilities in a multimillion-dollar investment to meet growing demand in the U.S.

This marks the first expansion to the drugmaker's Indianapolis manufacturing operations--making high-tech insulin cartridges--in more than 20 years, the company said.

Back to news